Navidea Biopharmaceuticals Inc (NAVBQ)

[petprodoc]

I think the wild card here is the FDA accepted study that includes survival data. Time will tell, but the accepted study, toxicology data, and whatever else the FDA has looked at will not hurt NEOPs potential chances for diagnostic approval.